Skip to content

The Move for Your Health Pilot Study

Replacing Sedentary Time With Light Activity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03632694
Enrollment
54
Registered
2018-08-15
Start date
2016-07-06
Completion date
2017-07-20
Last updated
2018-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

cancer survivor, cancer survivorship, light physical activity, sedentary behavior, mHealth, Jawbone

Brief summary

The Move for Your Health Pilot Study is a 16-week study in older cancer survivors to replace and break-up sedentary activity with short bouts of light physical activity.

Detailed description

This pilot study will determine the feasibility and acceptability of a mobile health (mHealth) intervention to replace and break-up sedentary time with intermittent bouts of light physical activity. The intervention uses an electronic activity monitor (Jawbone UP2; worn on the wrist) that pairs with a mobile app, which together promote awareness and enable self-monitoring of both physical activity (steps per day) and inactivity (wristband gently vibrates after a specified time of inactivity). Pre-post intervention change in objective, subjective, and biologic data will be compared between groups.

Interventions

BEHAVIORALHealth Coaching and Tech Support

Participants will receive a Jawbone UP2 activity monitor and education materials about the negative consequences of sedentary behavior and suggestions for breaking up sedentary time with light physical activity. Participants receive 5 telephone coaching calls to set up the Jawbone UP2 monitor with their smartphone app and receive tech support help with changing the settings/goals on the app. Additionally, this arm receives health coaching to provide encouragement and further motivate and help study participants to modify their sedentary behavior.

BEHAVIORALTech Support Only

Participants will receive a Jawbone UP2 activity monitor and education materials about the negative consequences of sedentary behavior and suggestions for breaking up sedentary time with light physical activity. Participants receive 5 telephone coaching calls to set up the Jawbone UP2 monitor with their smartphone app and receive tech support help with changing the settings/goals on the app. However, there is no additional health coaching.

Sponsors

University of New Mexico Cancer Center
CollaboratorOTHER
American Cancer Society, Inc.
CollaboratorOTHER
Cindy Blair, PhD, MPH
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Intervention model description

3-arm randomized controlled trial; participants were block randomized with equal allocation to 3 arms within 2 strata defined by body mass index (BMI; \<30 vs. \>=30 kg/m2)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 60 years or older at the time of enrollment * Diagnosed with local or regionally staged cancer (any site) and completed primary treatment * Own a smartphone capable of running the Jawbone UP2 app * Willingness to be randomized to any of the 3 study arms, attend 2 clinic visits, and wear activity monitors (activPAL and actiGraph) at weeks 1 and 16 for 7 days; Jawbone UP2 wristband monitor during weeks 2-16 during waking hours. * Able to read, speak, and understand English. * Living independently and capable of walking 3 blocks (approximately 1300 steps or 0.25 mile) without an assistive device (e.g., cane, walker) * Residence within Bernalillo County or the four surrounding counties (to reduce travel burden)

Exclusion criteria

* Currently participating in a program to decrease sedentary time or increase physical activity * Paid employment or volunteer position for greater than 20 hours per week * Severe impairments or pre-existing medical limitations for engaging in daily light physical activity * Wrist size \>20 cm

Design outcomes

Primary

MeasureTime frameDescription
Change in total volume of sedentary time (hours/day)Baseline to 16-weeksChange in the average number of hours/day of sedentary time measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention
Change in the number of breaks in sedentary timeBaseline to 16-weeksChange in the average number of breaks in sedentary time measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

Secondary

MeasureTime frameDescription
Change in physical performanceBaseline to 16-weeksChange in the average physical performance score as measured by the Short Physical Performance Battery (SPPB). This performance battery includes chair stands, balance tests, and the 8-foot usual gait speed. Each subscale score ranges from 0 (cannot do) to 4 (good performance). The subscales are summed for a total score, which ranges from 0 (lowest level of performance) to 12 (highest level of performance)
Change in physical functioning (ranging from basic to strenuous activities)Baseline to 16-weeksChange in self-reported physical functioning as measured by the 36-item Short Form Survey (SF-36) physical functioning subscale. Raw scores range from 0 (worst functioning) to 100 (best functioning)
Change in light physical activityBaseline to 16-weeksChange in the average number of hours per day spent in light physical activity (or higher intensity) measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention
Change in cardiometabolic markersBaseline to 16-weeksChange in fasting glucose, insulin and lipids, as well as high-sensitivity C-Reactive Protein (CRP)
Change in health-related quality of life (self-reported mental, physical, and social health and well-being)Baseline to 16-weeksChange in quality of life as measured by the SF-36; each of the 8 subscales and 2 component summary scores; scores based on proprietary algorithm from Optum; higher scores represent better quality of life)
Change in steps per dayBaseline to 16-weeksChange in the average number of steps per day measured over a 1-week period using activPAL, at both baseline and 16-weeks post-intervention

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026